Furthermore, Stat3 plays a critical role not only in the TKI-resistant lung cancer, but also in other multi-drug resistant malignancy including non-Hodgkin's lymphoma, multiple myeloma, epidermoid cell skin carcinoma, prostate carcinoma, and even self-renewal of cancer stem cells [37–41]. This evidence concerns the gene STAT3 and cancer.